| Literature DB >> 29588162 |
Fillipe M de Araújo1, Rafael S Ferreira2, Cleide S Souza2, Cleonice Creusa Dos Santos2, Tácio L R S Rodrigues2, Juliana Helena C E Silva2, Juciano Gasparotto3, Daniel Pens Gelain3, Ramon S El-Bachá2, Maria de Fátima D Costa2, José Claudio M Fonseca3, Juan Segura-Aguilar4, Silvia L Costa2, Victor Diogenes A Silva2.
Abstract
Recent evidence shows that aminochrome induces glial activation related to neuroinflammation. This dopamine derived molecule induces formation and stabilization of alpha-synuclein oligomers, mitochondria dysfunction, oxidative stress, dysfunction of proteasomal and lysosomal systems, endoplasmic reticulum stress and disruption of the microtubule network, but until now there has been no evidence of effects on production of cytokines and neurotrophic factors, that are mechanisms involved in neuronal loss in Parkinson's disease (PD). This study examines the potential role of aminochrome on the regulation of NGF, GDNF, TNF-α and IL-1β production and microglial activation in organotypic midbrain slice cultures from P8 - P9 Wistar rats. We demonstrated aminochrome (25 μM, for 24 h) induced reduction of GFAP expression, reduction of NGF and GDNF mRNA levels, morphological changes in Iba1+ cells, and increase of both TNF-α, IL-1β mRNA and protein levels. Moreover, aminochrome (25 μM, for 48 h) induced morphological changes in the edge of slices and reduction of TH expression. These results demonstrate neuroinflammation, as well as negative regulation of neurotrophic factors (GDNF and NGF), may be involved in aminochrome-induced neurodegeneration, and they contribute to a better understanding of PD pathogenesis.Entities:
Keywords: Gliosis; Neuroinflammation; Neuromelanin; Neurotrophin; Parkinson’s disease
Mesh:
Substances:
Year: 2018 PMID: 29588162 DOI: 10.1016/j.neuro.2018.03.009
Source DB: PubMed Journal: Neurotoxicology ISSN: 0161-813X Impact factor: 4.294